Invention Grant
- Patent Title: Pharmaceutical composition for inducing an immune response in a human or animal
-
Application No.: US10495511Application Date: 2002-11-29
-
Publication No.: US07771998B2Publication Date: 2010-08-10
- Inventor: Alexei Kirkin , Karine Djandjougazian , Jesper Zeuthen
- Applicant: Alexei Kirkin , Karine Djandjougazian , Jesper Zeuthen
- Applicant Address: DK Copenhagen O
- Assignee: Dandrit Biotech A/S
- Current Assignee: Dandrit Biotech A/S
- Current Assignee Address: DK Copenhagen O
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: DK200101770 20011129
- International Application: PCT/DK02/00802 WO 20021129
- International Announcement: WO03/045427 WO 20030605
- Main IPC: C12N5/071
- IPC: C12N5/071 ; A01N63/00
Abstract:
The present invention relates to a pharmaceutical composition for inducing an immune response in a human or animal, comprising dendritic cells loaded with at least five cancer/testis antigen and no lineage specific differentiation antigens or substantially no lineage specific differentiation antigens provided from at least one cancer cell line, as well as to isolated cell lines expressing a multiplicity of cancer testis antigens and no differentiation antigens, and to a method of inducing an immune response in a human or animal using the composition of the invention.
Public/Granted literature
- US20060051324A1 Pharmaceutical composition for inducing an immune response in a human or animal Public/Granted day:2006-03-09
Information query
